Skip to main content
Equibles

Cambridge Investment Research Advisors, Inc.

Position in TLRY — Tilray Brands, Inc.

CIK 1419186 FAIRFIELD, IA
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$188,678
+$37,708 QoQ
Shares Held
42,022
+80.1% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 235 holders
Holding Since
Mar 2020
26 quarters on record

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Cambridge Investment Research Advisors, Inc. holds $28,058,357 across 19 Drug Manufacturers - Specialty & Generic names. TLRY ranks #15 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LNTH
Lantheus Holdings, Inc.
 64,199 $7,122,237
2 PCRX
Pacira BioSciences, Inc.
 127,996 $3,247,258
3 UTHR
UNITED THERAPEUTICS Corp
 5,625 $3,047,793
4 TEVA
Teva Pharmaceutical Industries Ltd
 87,650 $2,969,582
5 HIMS
Hims & Hers Health, Inc.
 79,024 $2,739,762
6 ZTS
Zoetis Inc.
 34,463 $2,476,511
7 VTRS
Viatris Inc
 140,952 $2,238,317
8 NBIX
Neurocrine Biosciences Inc
 6,718 $1,132,251

All Filings in TLRY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $188,678 42,022
2026-03-31 $150,970 23,334
2025-12-31 $137,237 15,198
2025-09-30 $269,646 155,865
2025-06-30 $24,643 60,107
2025-03-31 $53,498 81,059
2024-12-31 $132,612 99,709
2024-09-30 $243,856 138,555
2024-06-30 $241,871 145,706
2024-03-31 $323,066 130,796
2023-12-31 $315,571 137,205
2023-09-30 $192,091 80,373
2023-06-30 $182,594 117,048
2023-03-31 $336,424 132,974
2022-12-31 $381,990 142,004
2022-09-30 $394,231 143,357
2022-06-30 $424,447 136,041
2022-03-31 $1,739,586 223,885
2021-12-31 $657,213 93,487
2021-09-30 $1,683,339 149,100
2021-06-30 $2,131,270 117,880
2021-03-31 $1,178,550 51,850
2020-12-31 $253,325 30,669
2020-09-30 $99,861 20,590
2020-06-30 $132,693 18,663
2020-03-31 $125,993 18,313